![Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis](https://oncodaily.com/pub/uploads/2024/03/Lea-Monteran-2-e1709939026684.jpg)
Photo taken from Lea Monteran/X
Mar 8, 2024, 19:03
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter:
“I am excited to share our latest work (and Ph.D.’s baby) with Neta Erez on breast cancer bone metastasis, showing how combining TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis. In Cancer Discovery.”
Proceed to the article.
Source: Lea Monteran/X